These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 20465372)

  • 1. The role of patient satisfaction in methadone treatment.
    Kelly SM; O'Grady KE; Brown BS; Mitchell SG; Schwartz RP
    Am J Drug Alcohol Abuse; 2010 May; 36(3):150-4. PubMed ID: 20465372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of methadone treatment retention from a multi-site study: a survival analysis.
    Kelly SM; O'Grady KE; Mitchell SG; Brown BS; Schwartz RP
    Drug Alcohol Depend; 2011 Sep; 117(2-3):170-5. PubMed ID: 21310552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient satisfaction with methadone maintenance treatment: the relevance of participation in treatment and social functioning.
    Trujols J; Garijo I; Siñol N; del Pozo J; Portella MJ; Pérez de los Cobos J
    Drug Alcohol Depend; 2012 Jun; 123(1-3):41-7. PubMed ID: 22071121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between drug treatment services, retention, and outcomes.
    Hser YI; Evans E; Huang D; Anglin DM
    Psychiatr Serv; 2004 Jul; 55(7):767-74. PubMed ID: 15232015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methadone maintenance treatment: the need to distinguish between holding dose, dose adequacy, satisfaction with methadone as a medication, and satisfaction with treatment.
    Trujols J; Siñol N; de los Cobos JP
    J Clin Psychopharmacol; 2010 Feb; 30(1):95-6; author reply 96. PubMed ID: 20075667
    [No Abstract]   [Full Text] [Related]  

  • 6. Pre-treatment characteristics, program philosophy and level of ancillary services as predictors of methadone maintenance treatment outcome.
    Saxon AJ; Wells EA; Fleming C; Jackson TR; Calsyn DA
    Addiction; 1996 Aug; 91(8):1197-209. PubMed ID: 8828247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elimination of methadone benefits in the Oregon Health Plan and its effects on patients.
    Fuller BE; Rieckmann TR; McCarty DJ; Ringor-Carty R; Kennard S
    Psychiatr Serv; 2006 May; 57(5):686-91. PubMed ID: 16675764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different components of opioid-substitution treatment predict outcomes of patients with and without a parent with substance-use problems.
    Trafton JA; Tracy SW; Oliva EM; Humphreys K
    J Stud Alcohol Drugs; 2007 Mar; 68(2):165-72. PubMed ID: 17286334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Premature discharge from methadone treatment: patient perspectives.
    Reisinger HS; Schwartz RP; Mitchell SG; Peterson JA; Kelly SM; O'Grady KE; Marrari EA; Brown BS; Agar MH
    J Psychoactive Drugs; 2009 Sep; 41(3):285-96. PubMed ID: 19999682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The impact of substitution treatment by methadone among opiate-dependent subjects evaluated by Addiction Severity Index and by urine tests].
    Trémeau F; Darreye A; Khidichian F; Weibel H; Kempf M; Greth P; Schneider JL; Wantz C; Weber B; Stépien S; Macher JP
    Encephale; 2002; 28(5 Pt 1):448-53. PubMed ID: 12386547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying methadone maintenance clients at risk for poor treatment response: pretreatment and early progress indicators.
    Morral AR; Belding MA; Iguchi MY
    Drug Alcohol Depend; 1999 Jun; 55(1-2):25-33. PubMed ID: 10402146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methadone medical maintenance in primary care. An implementation evaluation.
    Merrill JO; Jackson TR; Schulman BA; Saxon AJ; Awan A; Kapitan S; Carney M; Brumback LC; Donovan D
    J Gen Intern Med; 2005 Apr; 20(4):344-9. PubMed ID: 15857492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: a randomized controlled trial.
    Sees KL; Delucchi KL; Masson C; Rosen A; Clark HW; Robillard H; Banys P; Hall SM
    JAMA; 2000 Mar; 283(10):1303-10. PubMed ID: 10714729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled trial of prescribed heroin in the treatment of opioid addiction.
    March JC; Oviedo-Joekes E; Perea-Milla E; Carrasco F;
    J Subst Abuse Treat; 2006 Sep; 31(2):203-11. PubMed ID: 16919749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship of psychiatric comorbidity to treatment outcomes in methadone maintained patients.
    Cacciola JS; Alterman AI; Rutherford MJ; McKay JR; Mulvaney FD
    Drug Alcohol Depend; 2001 Feb; 61(3):271-80. PubMed ID: 11164691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and psychometric properties of the Verona Service Satisfaction Scale for methadone-treated opioid-dependent patients (VSSS-MT).
    de los Cobos J; Valero S; Haro G; Fidel G; Escuder G; Trujols J; Valderrama JC
    Drug Alcohol Depend; 2002 Oct; 68(2):209-14. PubMed ID: 12234650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methadone Medical Maintenance: An Early 21st-Century Perspective.
    Novick DM; Salsitz EA; Joseph H; Kreek MJ
    J Addict Dis; 2015; 34(2-3):226-37. PubMed ID: 26110221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Major depressive disorder and patient satisfaction in relation to methadone pharmacokinetics and pharmacodynamics in stabilized methadone maintenance patients.
    Elkader AK; Brands B; Dunn E; Selby P; Sproule BA
    J Clin Psychopharmacol; 2009 Feb; 29(1):77-81. PubMed ID: 19142113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 15-Year survival and retention of patients in a general hospital-affiliated methadone maintenance treatment (MMT) center in Israel.
    Peles E; Schreiber S; Adelson M
    Drug Alcohol Depend; 2010 Mar; 107(2-3):141-8. PubMed ID: 19914783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Client and counselor attitudes toward the use of medications for treatment of opioid dependence.
    Rieckmann T; Daley M; Fuller BE; Thomas CP; McCarty D
    J Subst Abuse Treat; 2007 Mar; 32(2):207-15. PubMed ID: 17306729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.